Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02463682 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02463682: Completed NA study, sponsored by Sansum Diabetes Research Institute.
NCT02463682 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02463682, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a feasibility study of an artificial pancreas (AP) system with our previously validated Zone-MPC and Health Monitoring System (HMS) algorithms (ClinicalTraisl.gov: NCT01929798) integrated into the Diabetes Assistant (DiAs) system.
Primary Outcome
The primary endpoint for this pilot study will be to determine the safety and efficacy of the system, as assessed by the composite outcome of time in range for glucose levels of 70-180 mg/dL and time \< 70 mg/dL, comparing between sensor-augmented pump use (open loop care) (week 1) to closed-loop care (final week), so as to determine the feasibility of eventual long-term use of the system.
Interventions
- DEVICE CGM and Insulin Pump
- DEVICE Closed-Loop Control System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT02463682 record still lists
NCT02463682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which CGM and Insulin Pump is the first listed.
NCT02463682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02463682 about?
NCT02463682 is a clinical study titled "Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting". This is a feasibility study of an artificial pancreas (AP) system with our previously validated Zone-MPC and Health Monitoring System (HMS) algorithms (ClinicalTraisl.gov: NCT01929798) integrated into the Diabetes Assistant (DiAs) system.
What is the current status of trial NCT02463682?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2015-05. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02463682?
The interventions under investigation include: CGM and Insulin Pump (DEVICE), Closed-Loop Control System (DEVICE).
Who is sponsoring clinical trial NCT02463682?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02463682's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia